Loading clinical trials...
Loading clinical trials...
Comparison of Medication Adherence Between Once Daily Tacrolimus (Advagraf®) and Twice Daily Tacrolimus (Prograf®) Administration in Stable Renal Transplant Recipients - a Randomized Study
Conditions
Interventions
Tacrolimus - Prograf® twice daily formulation
Tacrolimus - Advagraf® once daily formulation
Locations
1
Canada
Solid Organ Transplant Clinic, Vancouver General Hospital
Vancouver, British Columbia, Canada
Start Date
November 11, 2011
Primary Completion Date
October 30, 2014
Completion Date
March 1, 2018
Last Updated
May 17, 2018
NCT04634916
NCT06933472
NCT07146854
NCT04163614
NCT04580420
NCT07294183
Lead Sponsor
University of British Columbia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions